{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:12:54Z","timestamp":1784311974591,"version":"3.55.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,27]]},"DOI":"10.1097\/01.tp.0000269609.08495.45","type":"journal-article","created":{"date-parts":[[2007,7,26]],"date-time":"2007-07-26T08:04:43Z","timestamp":1185437083000},"page":"180-186","source":"Crossref","is-referenced-by-count":44,"title":["Chronic Ductopenic Rejection in Patients With Recurrent Hepatitis C Virus Treated With Pegylated Interferon Alfa-2a and Ribavirin"],"prefix":"10.1097","volume":"84","author":[{"given":"Carmen M.","family":"Stanca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Fiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolas","family":"Kontorinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukru","family":"Emre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.1840160403","article-title":"Hepatitis C viral infection in liver transplant recipients.","volume":"16","author":"Ferrell","year":"1992","journal-title":"Hepatology"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510240606","article-title":"Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions.","volume":"24","author":"Fukumoto","year":"1996","journal-title":"Hepatology"},{"key":"R3-8-20210129","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.qco.0000136934.06039.01","article-title":"Natural history of hepatitis C following liver transplantation.","volume":"17","author":"Rodriguez-Luna","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/hep.510290412","article-title":"Recurrent and new hepatitis C virus infection after liver transplantation.","volume":"29","author":"Everhart","year":"1999","journal-title":"Hepatology"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/jlts.2003.50268","article-title":"Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.","volume":"9","author":"Wiesner","year":"2003","journal-title":"Liver Transpl"},{"issue":"10 Suppl 1","key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1053\/jlts.2002.35781","article-title":"Natural history of recurrent hepatitis C.","volume":"8","author":"Berenguer","year":"2002","journal-title":"Liver Transpl"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1053\/jlts.2003.50248","article-title":"The natural history and outcome of liver transplantation in hepatitis C virus infected recipients.","volume":"9","author":"Gane","year":"2003","journal-title":"Liver Transpl"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/00007890-199201000-00023","article-title":"Preliminary experience with alpha-2b interferon therapy of viral hepatitis in liver allograft recipients.","volume":"53","author":"Wright","year":"1992","journal-title":"Transplantation"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840220411","article-title":"An open trial of interferon alfa recombinant for hepatitis C after liver transplantation: Antiviral effects and risk of rejection.","volume":"22","author":"Feray","year":"1995","journal-title":"Hepatology"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.510270530","article-title":"A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.","volume":"27","author":"Gane","year":"1998","journal-title":"Hepatology"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-200101270-00017","article-title":"Daily interferon therapy for hepatitis C virus infection in liver transplant recipients.","volume":"71","author":"Cotler","year":"2001","journal-title":"Transplantation"},{"issue":"S2","key":"R12-8-20210129","first-page":"22","article-title":"New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.","volume":"23","author":"Bizollon","year":"1995","journal-title":"J Hepatol"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0041-1345(98)00554-5","article-title":"Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin.","volume":"30","author":"Gotz","year":"1998","journal-title":"Transplant Proceed"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0041-1345(98)01725-4","article-title":"Treatment of severe recurrent hepatitis C after liver transplantation with ribavirin plus interferon alpha.","volume":"31","author":"Fischer","year":"1999","journal-title":"Transplant Proc"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1053\/gast.2003.50095","article-title":"Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: A randomized study.","volume":"124","author":"Samuel","year":"2003","journal-title":"Gastroenterology"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/lt.20074","article-title":"Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.","volume":"10","author":"Abdelmalek","year":"2004","journal-title":"Liver Transpl"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.transproceed.2005.10.060","article-title":"Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.","volume":"37","author":"Oton","year":"2005","journal-title":"Transplant Proceed"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C.","volume":"39","author":"Strader","year":"2004","journal-title":"Hepatology"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/lt.20865","article-title":"Treating hepatitis C infection in liver transplant recipients.","volume":"12","author":"Terrault","year":"2006","journal-title":"Liver Transpl"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/jlts.2002.31748","article-title":"A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation.","volume":"8","author":"Crippin","year":"2002","journal-title":"Liver Transpl"},{"key":"R21-8-20210129","first-page":"529","article-title":"A case of allograft rejection induced by the interferon-alpha therapy to hepatitis type C after renal transplantation.","volume":"40","author":"Kakimoto","year":"1994","journal-title":"Hinyokika Kiyo"},{"key":"R22-8-20210129","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection.","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"key":"R23-8-20210129","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000169133","article-title":"Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy.","volume":"17","author":"Izopet","year":"1997","journal-title":"Am J Nephrol"},{"issue":"4 Suppl 2","key":"R24-8-20210129","first-page":"A","article-title":"The risk of acute rejection in patients treated with pegylated interferon and ribavirin for recurrent hepatitis C post liver transplantation.","volume":"126","author":"Elhajj","year":"2004","journal-title":"Gastroenterology"},{"issue":"4 Suppl 1","key":"R25-8-20210129","first-page":"S21","article-title":"Acute and chronic hepatic allograft rejection: pathology and classification.","volume":"5","author":"Batts","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R26-8-20210129","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.510310337","article-title":"Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection.","volume":"31","year":"2000","journal-title":"Hepatology"},{"key":"R27-8-20210129","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/lt.20614","article-title":"Immunosuppression in liver transplantation.","volume":"11","author":"Post","year":"2005","journal-title":"Liver Transpl"},{"key":"R28-8-20210129","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/lt.20406","article-title":"Basic concepts in transplant immunology.","volume":"11","author":"Martinez","year":"2005","journal-title":"Liver Transpl"},{"key":"R29-8-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: A need for reassessment.","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"R30-8-20210129","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting.","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R31-8-20210129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/jhep.2002.31726","article-title":"Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.","volume":"35","author":"Neil","year":"2002","journal-title":"Hepatology"},{"key":"R32-8-20210129","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: An international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"R33-8-20210129","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1056\/NEJM199404213301618","article-title":"Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.","volume":"330","author":"Dousset","year":"1994","journal-title":"N Engl J Med"},{"key":"R34-8-20210129","first-page":"1627","article-title":"Alpha-interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimen.","volume":"59","author":"Gadano","year":"1995","journal-title":"Transplantation"},{"key":"R35-8-20210129","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/01.TP.0000100481.14514.BB","article-title":"Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha-2b and ribavirin: An open-label series.","volume":"77","author":"Rodriguez-Luna","year":"2004","journal-title":"Transplantation"},{"key":"R36-8-20210129","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/lt.20189","article-title":"Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.","volume":"10","author":"Stravitz","year":"2004","journal-title":"Liver Transpl"},{"key":"R37-8-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.20560","article-title":"Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials.","volume":"41","author":"Chalasani","year":"2005","journal-title":"Hepatology"},{"key":"R38-8-20210129","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/lt.20157","article-title":"Outcomes of acute rejection after interferon therapy in liver transplant recipients.","volume":"10","author":"Saab","year":"2004","journal-title":"Liver Transpl"},{"key":"R39-8-20210129","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007890-200103150-00019","article-title":"Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.","volume":"71","author":"De Vera","year":"2001","journal-title":"Transplantation"},{"key":"R40-8-20210129","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1053\/jlts.2002.34968","article-title":"Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.","volume":"8","author":"Firpi","year":"2002","journal-title":"Liver Transpl"},{"issue":"4 Suppl 1","key":"R41-8-20210129","first-page":"S30","article-title":"Incidence, timing, and risk factors for acute and chronic rejection.","volume":"5","author":"Neuberger","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R42-8-20210129","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/lt.20737","article-title":"Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C.","volume":"12","author":"Berenguer","year":"2006","journal-title":"Liver Transpl"},{"issue":"4, suppl. 1","key":"R43-8-20210129","first-page":"677A","article-title":"Differing immune effects of PEG-IFN-alpha 2B and IFN-alpha 2B combined with ribavirin for chronic hepatitis C.","volume":"42","author":"Ishii","year":"2005","journal-title":"Hepatology"},{"key":"R44-8-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.2006.092064","article-title":"High incidence of allograft dysfunction in liver transplant patients treated with Peg-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: Possible de novo autoimmune hepatitis?","volume":"56","author":"Berardi","year":"2007","journal-title":"Gut"},{"key":"R45-8-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archderm.141.7.865","article-title":"Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: A case report and review of the literature.","volume":"141","author":"Hurst","year":"2005","journal-title":"Arch Dermatol"},{"key":"R46-8-20210129","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/lt.20706","article-title":"Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.","volume":"12","author":"Kontorinis","year":"2006","journal-title":"Liver Transplant"},{"key":"R47-8-20210129","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0168-8278(03)00358-1","article-title":"Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin.","volume":"39","author":"Tang","year":"2003","journal-title":"J Hepatol"},{"key":"R48-8-20210129","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"R49-8-20210129","first-page":"328A","article-title":"Chronic rejection after liver transplantation: incidence, risk factors and outcomes in the era of tacrolimus\/MMF and interferon.","volume":"42","author":"Landry","year":"2005","journal-title":"Hepatology"},{"issue":"4 Suppl 1","key":"R50-8-20210129","first-page":"329A","article-title":"Ductopenia associated with the use of pegylated interferon in liver transplant recipients: Case control study.","volume":"42","author":"Nair","year":"2005","journal-title":"Hepatology"},{"key":"R51-8-20210129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/lt.500050519","article-title":"Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection.","volume":"5","author":"Wiesner","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R52-8-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/lt.20883","article-title":"Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C alter liver transplantation.","volume":"12","author":"Fernandez","year":"2006","journal-title":"Liver Transpl"},{"key":"R53-8-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/lt.20532","article-title":"Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.","volume":"12","author":"Firpi","year":"2006","journal-title":"Liver Transpl"},{"key":"R54-8-20210129","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1097\/00007890-200006150-00019","article-title":"Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: Long-term follow-up and evaluation of features for histopathological staging.","volume":"69","author":"Blakolmer","year":"2000","journal-title":"Transplantation"},{"key":"R55-8-20210129","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/00007890-199504270-00008","article-title":"CsA levels in the early posttransplant period\u2013predictive of chronic rejection in liver transplantation?","volume":"59","author":"Soin","year":"1995","journal-title":"Transplantation"},{"key":"R56-8-20210129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7150\/ijms.3.79","article-title":"Management of HCV infection and liver transplantation.","volume":"3","author":"Schiano","year":"2006","journal-title":"Int J Med Sci"},{"key":"R57-8-20210129","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1053\/jlts.2003.50233","article-title":"Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"key":"R58-8-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1365-2036.2005.02502.x","article-title":"Effect of hepatitis C infection on tacrolimus doses and blood levels in liver transplantation recipients.","volume":"22","author":"Trotter","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R59-8-20210129","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1053\/jlts.2003.50250","article-title":"Treatment of hepatitis C virus infection in the allograft.","volume":"9","author":"Neuberger","year":"2003","journal-title":"Liver Transpl"},{"key":"R60-8-20210129","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/jlts.2003.50062","article-title":"Duration of antiviral therapy for cholestatic HCV recurrence may need to be indefinite.","volume":"9","author":"Gopal","year":"2003","journal-title":"Liver Transpl"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.tp.0000269609.08495.45","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:17:29Z","timestamp":1620940649000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200707270-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,27]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000269609.08495.45","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7,27]]}}}